With its recent agreement to buy rival Solectron for $3.6 billion, Flextronics is hoping that it will gain the manufacturing and marketing muscle needed to keep pace with its other foreign rivals
Tags: Money Morning Staff
This overdose cure shortage is another catalyst for our medical cannabis biotech…
Chronic pain can’t be ignored. It can affect your productivity, family life, parenting, budget – and more.
Fact is, the population is aging, with lots of people in pain. It’s only going to get worse.